HER2-Low Breast Cancer : Pathological and Clinical Landscape
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 38(2020), 17 vom: 10. Juni, Seite 1951-1962 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tarantino, Paolo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 22.02.2021 Date Revised 22.02.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1200/JCO.19.02488 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309144019 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309144019 | ||
| 003 | DE-627 | ||
| 005 | 20231225133249.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.19.02488 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1030.xml |
| 035 | |a (DE-627)NLM309144019 | ||
| 035 | |a (NLM)32330069 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tarantino, Paolo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HER2-Low Breast Cancer |b Pathological and Clinical Landscape |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.02.2021 | ||
| 500 | |a Date Revised 22.02.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Cancer Vaccines |2 NLM | |
| 650 | 7 | |a Immunotoxins |2 NLM | |
| 650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
| 650 | 7 | |a ERBB2 protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 650 | 7 | |a Receptor, ErbB-2 |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Hamilton, Erika |e verfasserin |4 aut | |
| 700 | 1 | |a Tolaney, Sara M |e verfasserin |4 aut | |
| 700 | 1 | |a Cortes, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Morganti, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Ferraro, Emanuela |e verfasserin |4 aut | |
| 700 | 1 | |a Marra, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Viale, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Trapani, Dario |e verfasserin |4 aut | |
| 700 | 1 | |a Cardoso, Fatima |e verfasserin |4 aut | |
| 700 | 1 | |a Penault-Llorca, Frédérique |e verfasserin |4 aut | |
| 700 | 1 | |a Viale, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Andrè, Fabrice |e verfasserin |4 aut | |
| 700 | 1 | |a Curigliano, Giuseppe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology : official journal of the American Society of Clinical Oncology |d 1986 |g 38(2020), 17 vom: 10. Juni, Seite 1951-1962 |w (DE-627)NLM012608777 |x 1527-7755 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2020 |g number:17 |g day:10 |g month:06 |g pages:1951-1962 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.19.02488 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2020 |e 17 |b 10 |c 06 |h 1951-1962 | ||